Tectonic Therapeutic TECX
NASDAQ TECX
$30.75 +0.83 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026)

Tectonic Therapeutic (TECX) posted quarterly Non-Current Assets of $6.7 million for Q1 2026, up 28.92% year-over-year from $5.2 million in Q1 2025, and up 81.73% quarter-over-quarter from $3.7 million in Q4 2025.

Analysis

Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has reported Non-Current Assets for 10 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Assets rose 28.92% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $18.6 million (down 22.14% YoY), while the FY2025 annual figure was $3.7 million, down 39.17% from the prior year.
  • Non-Current Assets climbed to $6.7 million in Q1 2026 per TECX's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $8.5 million in Q4 2023 and bottomed at $510000.0 in Q1 2024.
  • Historically, Non-Current Assets has averaged $4.7 million across 5 years, with a median of $4.5 million in 2025.
  • Annual changes were most pronounced in 2024 — Non-Current Assets slumped 91.14% — and 2025, when it jumped 916.86%.
  • Tectonic Therapeutic's Non-Current Assets stood at $4.0 million in 2022, then surged by 113.36% to $8.5 million in 2023, then retreated by 28.97% to $6.0 million in 2024, then tumbled by 39.17% to $3.7 million in 2025, then soared by 81.73% to $6.7 million in 2026.
  • Business Quant data shows TECX's Non-Current Assets at $6.7 million in Q1 2026, $3.7 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 Tectonic Therapeutic 589.02 Mn 589.02 Mn - 5.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.94 Mn
Mar 31, 2026 6.69 Mn
Dec 31, 2025 3.68 Mn
Sep 30, 2025 3.76 Mn
Jun 30, 2025 4.47 Mn
Mar 31, 2025 5.19 Mn
Dec 31, 2024 6.05 Mn
Sep 30, 2024 6.12 Mn
Jun 30, 2024 6.52 Mn
Mar 31, 2024 510,000.00
Dec 31, 2023 8.52 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 4.99 Mn
Mar 31, 2023 5.75 Mn
Dec 31, 2022 3.99 Mn
Sep 30, 2022 3.26 Mn
Jun 30, 2022 4.16 Mn
Mar 31, 2022 4.42 Mn
Dec 31, 2021 4.69 Mn
Sep 30, 2021 4.80 Mn